Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Total Liabilities (2023 - 2025)

Historic Total Liabilities for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $69.5 million.

  • Metagenomi's Total Liabilities fell 3225.44% to $69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.5 million, marking a year-over-year decrease of 3225.44%. This contributed to the annual value of $89.7 million for FY2024, which is 4003.93% down from last year.
  • As of Q3 2025, Metagenomi's Total Liabilities stood at $69.5 million, which was down 3225.44% from $76.5 million recorded in Q2 2025.
  • Over the past 5 years, Metagenomi's Total Liabilities peaked at $149.7 million during Q4 2023, and registered a low of $119021.0 during Q3 2023.
  • Its 3-year average for Total Liabilities is $92.9 million, with a median of $90.0 million in 2023.
  • Over the last 5 years, Metagenomi's Total Liabilities had its largest YoY gain of 8608227.04% in 2024, and its largest YoY loss of 4003.93% in 2024.
  • Metagenomi's Total Liabilities (Quarter) stood at $149.7 million in 2023, then tumbled by 40.04% to $89.7 million in 2024, then fell by 22.57% to $69.5 million in 2025.
  • Its Total Liabilities stands at $69.5 million for Q3 2025, versus $76.5 million for Q2 2025 and $85.2 million for Q1 2025.